Recent evidence indicates that TRPM8 protein undergoes ubiquitin-mediated degradation in prostate cancer cells, and the TRPM8 channel activity on the plasma membrane could be increased by inhibiting the initial enzyme in ubiquitination [35]. This evidence concerns the gene TRPM8 and prostate carcinoma.